You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

carfilzomib

Showing 26 - 50 of 133
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Chicago, Evanston, Ann Arbor (Elotuzumab, Carfilzomib, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +2 more
Nov 12, 2021

Multiple Myeloma Trial in Chicago, Detroit, Poznan (Lenalidomide, Carfilzomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +2 more
Jun 29, 2021

Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage I Adult

Completed
  • Contiguous Stage II Adult Lymphoblastic Lymphoma
  • +5 more
  • carfilzomib
  • +10 more
  • Sacramento, California
    University of California Davis
Mar 8, 2022

Multiple Myeloma Trial in Maywood (Carfilzomib, Busulfan IV, Melphalan IV)

Recruiting
  • Multiple Myeloma
  • Carfilzomib
  • +2 more
  • Maywood, Illinois
    Loyola University Medical Center
Apr 23, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Carfilzomib, Dexamethasone, Pomalidomide)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Carfilzomib
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 3, 2022

Myeloma Multiple, Myeloma, Plasma-Cell, Myeloma-Multiple Trial in Israel (Carfilzomib, Daratumumab, Lenalidomide)

Completed
  • Myeloma Multiple
  • +3 more
  • Carfilzomib
  • +3 more
  • Afula, Israel
  • +13 more
Jan 26, 2022

Multiple Myeloma Trial in United States (panobinostat, carfilzomib)

Completed
Has Results
  • Multiple Myeloma
  • Denver, Colorado
  • +12 more
Jan 4, 2022

Multiple Myeloma Trial in Canada (Carfilzomib, Cyclophosphamide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Carfilzomib
  • +2 more
  • Edmonton, Alberta, Canada
  • +8 more
Feb 1, 2022

Multiple Myeloma Trial in Chicago (Carfilzomib, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Carfilzomib
  • +3 more
  • Chicago, Illinois
    University Of Chicago Medicine Comprehensive Cancer Center
Jun 7, 2021

Myeloma Trial in Denmark, Norway, Sweden (Carfilzomib, Lenalidomide, PET-CT)

Recruiting
  • Myeloma
  • Carfilzomib
  • +3 more
  • Copenhagen, Denmark
  • +3 more
Sep 15, 2021

Multiple Myeloma Trial run by the NCI (Carfilzomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Carfilzomib
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 10, 2021

Multiple Myeloma Trial in United States (Carfilzomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Carfilzomib
  • +4 more
  • Birmingham, Alabama
  • +11 more
Aug 11, 2022

Multiple Myeloma Trial in United States (daratumumab, carfilzomib, lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Nov 16, 2021

Lymphoma, Non-Hodgkin, Lymphoma Trial in Davis, San Diego, San Francisco (Carfilzomib, Bendamustine, Rituximab)

Completed
  • Lymphoma, Non-Hodgkin
  • Lymphoma
  • Carfilzomib
  • +2 more
  • Davis, California
  • +2 more
Apr 21, 2021

Multiple Myeloma Trial in United States (Elotuzumab, Pomalidomide, Carfilzomib)

Terminated
  • Multiple Myeloma
  • Encinitas, California
  • +5 more
Mar 15, 2022

Multiple Myeloma Trial in Austria, Germany (Carfilzomib, Thalidomide, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Carfilzomib
  • +3 more
  • Graz, Austria
  • +20 more
Jan 18, 2022

Multiple Myeloma Trial in Canada, United States (Ibrutinib, Carfilzomib, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Duarte, California
  • +16 more
Nov 24, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (drug, biological, other)

Not yet recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Carfilzomib
  • +4 more
  • Des Moines, Iowa
  • +8 more
Aug 16, 2022

Relapsed/Refractory Multiple Myeloma Trial in Worldwide (BGB-11417, Dexamethasone, Carfilzomib)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Birmingham, Alabama
  • +21 more
Aug 8, 2022

Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)

Recruiting
  • Multiple Myeloma in Relapse
  • Aurora, Colorado
    University of Colorado Hospital
Dec 30, 2021

Multiple Myeloma Trial in Spain (Carfilzomib, Dexamethasone, cyclophosphamide)

Active, not recruiting
  • Multiple Myeloma
  • Carfilzomib
  • +2 more
  • Tenerife, Islas Canarias, Spain
  • +23 more
Apr 1, 2021

CD20 Positive, Recurrent DLBCL, Refractory DLBCL Trial in Buffalo (drug, other, biological)

Active, not recruiting
Has Results
  • CD20 Positive
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 11, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Bendamustine Hydrochloride, Carfilzomib,

Completed
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Bendamustine Hydrochloride
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 7, 2021

Multiple Myeloma Trial in Spain (REGN5458, Daratumumab, Carfilzomib)

Recruiting
  • Multiple Myeloma
  • Santander, Cantabria, Spain
  • +3 more
Aug 18, 2022

Amyloidosis Trial in United Kingdom (Carfilzomib, Thalidomide, Dexamethasone)

Completed
Has Results
  • Amyloidosis
  • Carfilzomib
  • +2 more
  • Plymouth, Devon, United Kingdom
  • +13 more
Mar 18, 2021